Literature DB >> 22222078

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

Rashmee U Shah1, James V Freeman, David Shilane, Paul J Wang, Alan S Go, Mark A Hlatky.   

Abstract

OBJECTIVES: The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization rates for arrhythmia recurrence following atrial fibrillation (AF) ablation.
BACKGROUND: AF is the most common clinically significant arrhythmia and is associated with increased morbidity and mortality. Radiofrequency or cryotherapy ablation of AF is a relatively new treatment option, and data on post-procedural outcomes in large general populations are limited.
METHODS: Using data from the California State Inpatient Database, we identified all adult patients who underwent their first AF ablation from 2005 to 2008. We used multivariable logistic regression to identify predictors of complications and/or 30-day readmissions and Kaplan-Meier analyses to estimate rates of all-cause and arrhythmia readmissions.
RESULTS: Among 4,156 patients who underwent an initial AF ablation, 5% had periprocedural complications, most commonly vascular, and 9% were readmitted within 30 days. Older age, female, prior AF hospitalizations, and less hospital experience with AF ablation were associated with higher adjusted risk of complications and/or 30-day readmissions. The rate of all-cause hospitalization was 38.5% by 1 year. The rate of readmission for recurrent AF, atrial flutter, and/or repeat ablation was 21.7% by 1 year and 29.6% by 2 years.
CONCLUSIONS: Periprocedural complications occurred in 1 of 20 patients undergoing AF ablation, and all-cause and arrhythmia-related rehospitalizations were common. Older age, female sex, prior AF hospitalizations, and recent hospital procedure experience were associated with a higher risk of complications and/or 30-day readmission after AF ablation.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22222078      PMCID: PMC5340189          DOI: 10.1016/j.jacc.2011.08.068

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

2.  Hospital and surgeon determinants of carotid endarterectomy outcomes.

Authors:  Thomas E Feasby; Hude Quan; William A Ghali
Journal:  Arch Neurol       Date:  2002-12

3.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

Authors:  Giuseppe Stabile; Emanuele Bertaglia; Gaetano Senatore; Antonio De Simone; Franco Zoppo; Giovanni Donnici; Pietro Turco; Pietro Pascotto; Massimo Fazzari; Dino Franco Vitale
Journal:  Eur Heart J       Date:  2005-10-07       Impact factor: 29.983

4.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

5.  Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.

Authors:  Edgar Argulian; Amar D Patel; Jerome L Abramson; Aniket Kulkarni; Kimberly Champney; Spencer Palmer; William Weintraub; Nanette K Wenger; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2006-05-04       Impact factor: 2.778

6.  The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry.

Authors:  James V Freeman; Yongfei Wang; Jeptha P Curtis; Paul A Heidenreich; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

7.  Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

Authors:  Rukshen Weerasooriya; Paul Khairy; Jean Litalien; Laurent Macle; Meleze Hocini; Frederic Sacher; Nicolas Lellouche; Sebastien Knecht; Matthew Wright; Isabelle Nault; Shinsuke Miyazaki; Christophe Scavee; Jacques Clementy; Michel Haissaguerre; Pierre Jais
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

8.  Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries.

Authors:  Ethan R Ellis; Steven D Culler; April W Simon; Matthew R Reynolds
Journal:  Heart Rhythm       Date:  2009-06-06       Impact factor: 6.343

9.  Procedural volume as a marker of quality for CABG surgery.

Authors:  Eric D Peterson; Laura P Coombs; Elizabeth R DeLong; Constance K Haan; T Bruce Ferguson
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

10.  Predicting vascular complications in percutaneous coronary interventions.

Authors:  Winthrop D Piper; David J Malenka; Thomas J Ryan; Samuel J Shubrooks; Gerald T O'Connor; John F Robb; Karen L Farrell; Mary S Corliss; Michael J Hearne; Mirle A Kellett; Matthew W Watkins; William A Bradley; Bruce D Hettleman; Theodore M Silver; Paul D McGrath; John R O'Mears; David E Wennberg
Journal:  Am Heart J       Date:  2003-06       Impact factor: 4.749

View more
  68 in total

1.  Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications?

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2012-03-09       Impact factor: 1.900

Review 2.  Atrial fibrillation ablation in octogenarians: where do we stand?

Authors:  Gevorg Stepanyan; Edward P Gerstenfeld
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

3.  Maternal and Fetal Outcomes of Admission for Delivery in Women With Congenital Heart Disease.

Authors:  Robert M Hayward; Elyse Foster; Zian H Tseng
Journal:  JAMA Cardiol       Date:  2017-06-01       Impact factor: 14.676

4.  Treatment Complications of Atrial Fibrillation and Their Management.

Authors:  Allan Mattia; Joshua Newman; Frank Manetta
Journal:  Int J Angiol       Date:  2020-03-05

5.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

6.  Administrative billing codes accurately identified occurrence of electrical cardioversion and ablation/maze procedures in a prospective cohort study of atrial fibrillation patients.

Authors:  Alexa N Ehlert; Susan R Heckbert; Kerri L Wiggins; Evan L Thacker
Journal:  Clin Cardiol       Date:  2017-12-06       Impact factor: 2.882

Review 7.  A contemporary review on the genetic basis of atrial fibrillation.

Authors:  Jason D Roberts; Michael H Gollob
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jan-Mar

Review 8.  Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined?

Authors:  Roberta C Bogaev
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

9.  Strategies for Risk Analysis and Disease Classification in Atrial Fibrillation.

Authors:  Sara Adelman; Georges Daoud; Peter J Mohler
Journal:  J Cardiovasc Electrophysiol       Date:  2016-09-20

Review 10.  New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?

Authors:  Peter J Kudenchuk
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.